Electrotransfer of plasmid DNA has been demonstrated to be a viable approach to achieve effective delivery and has been tested in a variety of tissues. Sets of electrotransfer parameters, which includes electric fi eld strength, pulse duration, number of pulses, electrode geometry and confi guration, can be chosen to deliver plasmid DNA in such a way as to manipulate the onset, level, and duration of protein expression. Electrotransfer has been utilized to effectively deliver plasmids to many tissue targets. One target that has shown success is delivery to tumors. Electrotransfer of plasmids encoding cytokines directly to tumors has been shown to generate a local and systemic anti-tumor effect in both preclinical and clinical studies. To obtain the appropriate immune stimulation it is critical to achieve the appropriate balance between transgene expression and tissue damage. In this study we have evaluated various electrotransfer parameters, electrodes and expression levels of pDNA on the outcome of two different cytokines pIL-12 and pIL-15. Plasmid DNA was injected into established tumors of C57BL/6 mice and electric pulses applied three times over a one week period. The pulses applied were either high voltage, short duration (HVSD) or low voltage, long duration (LDLV). These conditions generate electric fi elds that mediate different effi ciencies of gene transfer. The tumor volumes were measured for several weeks after which the surviving mice were challenged by subcutaneous injection of B16.F10 melanoma cells on the opposite fl ank. Gene expression was measured by ELISA after a single treatment. Tissue sections were collected for histology at 24 hours after a single treatment. Expression levels and kinetics of the delivered transgene directly related to long-term disease free survival and protection following subsequent challenge. To achieve these results different delivery parameters were needed when delivering IL-12 versus IL-15. H E staining revealed more damage to tumors treated with LVLD pulses than HVSD pulses. Tumor infi ltrating lymphocytes were present in most of the electrotransfer treated tumors but there were more CD4+ and CD8a+ cells in the tumors treated with IL12. These results indicate appropriate levels of cytokine expression in tumors delivered by electrotransfer necessary for generating local and systemic anti-tumor response that correspond with a more successful outcome. This fi nding is important in order to improve electrotransfer-based therapies for melanoma patients. Voltage preconditioning allows for controlled, modulated loading of siRNA in diffi cult-to-transfect cells like primary hippocampal neurons. We showed previously that transfection effi ciency of >95% with negligible loss in viability could be achieved in primary neurons using voltage preconditioning. In addition, the technique allows for voltage-controlled uptake of siRNA with maximum loading occurring at -1 V and minimum loading occurring at +3 V. In this study we extend the cell preconditioning method to demonstrate controlled, dose-dependent, functional knockdown of BACE1 in small populations of primary hippocampal neurons (7 days in vitro) grown on microelectrode arrays (MEAs). BACE1 is a key target in the development of therapeutics for Alzheimer's disease and has been demonstrated to play a key regulatory role in the gene expression of Nav1.1 ion channels in neurons. Here, primary rat hippocampal neurons were dissociated and cultivated on transparent MEAs custom fabricated in-house using a photolithographic process. BACE1 siRNA were precomplexed with polyethyleneimine (PEI) and delivered to neuronal cells on individual microelectrodes (100 μm diameter) using the cell preconditioning method. Individual electrodes were subjected to brief voltage pulses at -1 V, 0 V, or +3 V, corresponding to high, medium, and low uptake of siRNA. Fluorescent siRNA that were co-transfected with BACE1 siRNA showed cells with high intensities (hence high uptake) at -1 V compared to +3 V. The extracellular action potentials of transfected neurons were measured using Plexon™ Systems before preconditioning and 30 min after the transfection process. The relative change in number of action potentials generated (fi ring rate) in neurons loaded with BACE1 siRNA at -1 V was >50% compared to <10% for cells preconditioned at +3 V. Transfection of cells at 0 V (PEI based transfection only) resulted in moderate change of 45-60% in fi ring rate. Corroborative studies demonstrating the partial knockdown of BACE1 using RT-PCR are currently in progress. We conclude that voltage preconditioning mediated modulation of BACE1 expression causes signifi cant changes in electrical activity of single neurons as early as 30 min post-transfection. Future applications include targeted, site-specifi c uptake in vivo. Hemophilia A is a genetic bleeding disorder that resulted from a defi ciency of blood clotting factor VIII. Gene therapy has been an important development for better treatment for hemophilia patients. We have previously reported that novel ultrasound (US) systems with microbubbles (MBs) serving as a potential non-viral physical delivery strategy can signifi cantly enhance gene transfer effi ciency of reporter plasmids. In this study, we delivered therapeutic FVIII plasmid into the livers of hemophilia A mice. Since FVIII synthesis can occur in multiple tissues/cell types, we fi rst explored the distribution of gene delivery and expression using a pGL4.13 [luc2/SV40] luciferase plasmid driven by a SV40 ubiquitous promoter. One day following gene transfer, hepatocytes and endothelia cells were isolated from treated lobe by liver perfusion and centrifuge method. Luciferase levels in two cell populations were evaluated respectively. The results indicated that luciferase predominantly expressed in hepatocytes
Targeted Modulation of BACE1 Expression and Electrical Activity in Neuronal Cultures

Ultrasound and Microbubbles Mediated Factor VIII Plasmid Gene Therapy in Hemophilia A Mice
